EFFECT - Efficacy of Fluticasone/Formoterol in COPD Treatment

• Research type

  Research Study

• Full title

  A randomised, double-blind, double dummy, parallel group study comparing Fluticasone propionate / formoterol fumarate (flutiform®) 250/10 µg (2 puffs BID) and flutiform® 125/5 µg (2 puffs BID) versus Formoterol fumarate dihydrate(Atimos®) 12 µg (1 puff BID) in subjects with chronic obstructive pulmonary disease (COPD).

• IRAS ID

  124938

• Contact name

  Adam Ellery

• Contact email

  Adam.Ellery@cape-cornwall.cornwall.nhs.uk

• Sponsor organisation

  Mundipharma Research Limited

• Eudract number

  2012-004162-17

• ISRCTN Number

  n/a

• REC name

  South West - Cornwall & Plymouth Research Ethics Committee

• REC reference

  13/SW/0186

• Date of REC Opinion

  25 Jul 2013

• REC opinion

  Further Information Favourable Opinion